Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

A Labrador Retriever with pemphigus fully recovered after six weeks of azathioprine treatment.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Isotretinoin effectively improved severe pityriasis rubra pilaris with complications.

Ritlecitinib can help about 14,000 people with severe hair loss.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Tofacitinib treatment is used for teenagers with alopecia areata.

Intralesional methotrexate effectively treats alopecia areata by reducing TNF-α levels, leading to hair regrowth.

ITK inhibitors may effectively treat alopecia areata.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Enhancing Tregs can protect against alopecia areata.